-
Continuous Manufacturing Part 3: Continuous Manufacturing in China
Deepak Hegde
February 05, 2024
This article, which is Part 3 and the concluding part of the series on continuous manufacturing focuses on CM in China and adoption of CM for biologic products.
-
Continuous Manufacturing Part 2: Challenges Open to CM
Deepak Hegde
February 05, 2024
This article, which is Part 2 of the series on continuous manufacturing focuses on the challenges still open to CM after the publication of ICH Q13 Guidance document and how CM could contribute to in-shoring back to US.
-
Continuous Manufacturing Part 1: Changes in Global Regulatory Landscape
Deepak Hegde
February 05, 2024
It's been about three years since I had written the three-part series of articles on Continuous Manufacturing (CM). Since then, a lot of water has flown under the bridge and there have been several developments in the field of CM. Now is probably the righ
-
Antibody Therapy Rescues Mice from Lethal Nerve-Muscle Disease
firstwordpharma
June 24, 2021
Researchers rescued mice from early death caused by a muscle-weakening disease, not by correcting the flawed gene that causes it, but instead by targeting another protein in the same signaling pathway.
-
HDMA highlights concerns of pharma industry in a letter to CM
expresspharma
April 21, 2020
The challenges faced by the pharma industry in Himachal Pradesh due to the nationwide lockdown has compelled the Himachal Drug Manufacturers Association (HDMA) to send a letter to Jai Ram Thakur, Chief Minister, Himachal Pradesh.
-
Significant Changes to Happen to the Pharmaceutical Industry as FDA Introduces the Continuous Manufacturing Guidance
PharmaSources/zhulikou431
March 12, 2019
The U.S. FDA has successively introduced the continuous manufacturing (CM) concept for some time, and encouraged some leading enterprises to apply for the pilot program.